• Non-invasive
• Systemic assessment
• Accurate and repeatable
• User friendly
• Immediate reporting
  

It starts in the wall

The standard test for screening patients for CVD is with an upper-arm blood pressure cuff device, or sphygmomanometer. While the cuff yields some information about individuals and patient populations, this is often limited in terms of positively identifying the presence of blood vessel disease.

The HDI/PulseWave™ CR-2000 CardioVascular Profiling Instrument uses an advanced technology developed at the University of Minnesota, which enables the detection of vascular disease at the earliest stages. It provides a sensitive, non-invasive way to measure changes in the elasticity of both small and large arteries. Its proprietary, patented Arterial Waveform Analysis methodology is fast, reliable, and easy to use.

The small and large artery elasticity indices are particularly important in identifying individuals who exhibit the development of vascular disease, and enables the physician to begin appropriate treatment long before the symptoms or clinical signs appear. The CR-2000 has many applications including:

• Hypertension
• Borderline Hypertension
• Hyperlipidemia
• Heart Failure
• Endothelial Function